Guidance on investigating cases, clusters and outbreaks of Legionnaires’ disease: For Public Health England health protection teams – Public Health England

The guidance brings together information on Legionnaires’ disease from Public Health England and other organisations to: set out roles and responsibilities for public health investigation and enforcement highlight specific considerations for investigation of potential sources of infection in healthcare, travel

Detection and enumeration of Listeria monocytogenes and other Listeria species: National Infection Service Food Water and Environmental Microbiology Standard Method – Public Health England

The method described is applicable to the detection and enumeration of Listeria monocytogenes and other Listeria species in all food types. These include milk and dairy products, and in environmental samples. These methods are well referenced and represent a good

Detection of Salmonella species: National Infection Service Food Water and Environmental Microbiology Standard Method – Public Health England

This document details a method for detecting Salmonella species in all food types, including: milk and dairy products raw molluscan shellfish raw shell eggs This method also applies to detection of Salmonella in environmental samples, such as swabs and cloths.

UK Standards for Microbiology: Investigations Vertical and perinatal transmission of hepatitis C – Public Health England

Information on UK Standards for Microbiology Investigations for vertical and perinatal transmission of hepatitis C.

EU Exit Operational Readiness Guidance: Actions the health and care system in England should take to prepare for a ‘no deal’ scenario – Department of Health and Social Care

Actions that providers and commissioners of health and social care services should take to prepare for, and manage, the risks of a no-deal exit scenario. Guidance, developed and agreed with NHS England and NHS Improvement, will support the health and

Consent to cancer screening, 2nd ed: (Cancer Screening Series No 4) – NHS Cancer Screening Programmes

These guidelines give commissioners, providers and healthcare professionals in cancer screening information on consent to screening and procedures. The document covers information and advice on: breast screening cervical screening bowel cancer screening mental capacity and consent It also provides several template

Interim protocol on dispensing of adrenaline auto-injectors, 150microgram – NHS England

This guidance on the dispensing of adrenaline auto-injectors (150microgram) has been developed for pharmacies and dispensing GP practices. This validation protocol has been developed to ensure consistent practice nationally and to prevent the need for any local re-interpretation.

Standards of proficiency for nursing associates – Nursing and Midwifery Council

The standards of proficiency presented here represent the standards of knowledge and skills that a nursing associate will need to meet in order to be considered by the NMC as capable of safe and effective nursing associate practice. These standards

Guidelines for Health & Justice Clinical Reviewers – NHS England

This document provides NHS England Health & Justice Commissioning Teams and Clinical Reviewers with national operating procedures and guidelines for the provision of Clinical Review reports to the Prisons and Probation Ombudsman (PPO).  

Guidelines for Health & Justice Clinical Reviewers – NHS England

This document provides NHS England Health & Justice Commissioning Teams and Clinical Reviewers with national operating procedures and guidelines for the provision of Clinical Review reports to the Prisons and Probation Ombudsman (PPO).  

Renal replacement therapy and conservative management: NICE guideline [NG107] – NICE

This guideline covers renal replacement therapy (dialysis and transplantation) and conservative management for people with chronic kidney disease stages 4 and 5. It aims to improve quality of life by making recommendations on planning, starting and switching treatments, and coordinating

Decision-making and mental capacity: NICE guideline [NG108] – NICE

This guideline covers decision-making in people 16 years and over who may lack capacity now or in the future. It aims to help health and social care practitioners support people to make their own decisions where they have the capacity

Cabozantinib for untreated advanced renal cell carcinoma: Technology appraisal guidance [TA542] – NICE

Evidence-based recommendations on cabozantinib (Cabometyx) for untreated advanced renal cell carcinoma in adults. Cabozantinib is recommended, within its marketing authorisation, for adults with untreated advanced renal cell carcinoma that is intermediate‑ or poor‑risk as defined in the International Metastatic Renal

Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs: Technology appraisal guidance [TA543] – NICE

Evidence-based recommendations on tofacitinib (Xeljanz) for treating active psoriatic arthritis in adults after inadequate response to DMARDs. It recommends:  Tofacitinib, with methotrexate, is recommended as an option for treating active psoriatic arthritis in adults, only if: it is used as

Cardiac arrhythmias in coronary heart disease: SIGN 152 – Scottish Intercollegiate Guidelines Network

This guideline provides evidence-based recommendations for the management of cardiac arrest and the arrhythmias associated with acute coronary syndrome (ACS), chronic CHD and cardiac surgery. It excludes arrhythmias not associated with CHD such as supraventricular tachycardias associated with accessory pathways

iFuse for treating chronic sacroiliac joint pain: Medical technologies guidance [MTG39] – NICE

Evidence-based recommendations on iFuse for treating chronic sacroiliac joint pain. The case for adopting the iFuse implant system to treat chronic sacroiliac joint pain is supported by the evidence. Using iFuse leads to improved pain relief, better quality of life

myAIRVO2 for the treatment of chronic obstructive pulmonary disease: Medtech innovation briefing [MIB161] – NICE

NICE has developed a medtech innovation briefing (MIB) on myAIRVO2 for the treatment of chronic obstructive pulmonary disease. The technology described in this briefing is myAIRVO2. It is designed to warm and humidify respiratory gases used for nasal high-flow therapy. This briefing

E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta: Medical technologies guidance [MTG16] – NICE

Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta. This guidance has been updated to include a review of the cost model using more recent values. New evidence and updated costs identified

OxyMask for delivering oxygen therapy: Medtech innovation briefing [MIB160] – NICE

NICE has developed a medtech innovation briefing (MIB) on OxyMask for delivering oxygen therapy. The technology described in this briefing is OxyMask. It is used for delivering oxygen therapy. The innovative aspect is the novel design, which is intended to improve the efficiency and

Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancer: Interventional procedures guidance [IPG628] – NICE

Evidence-based recommendations on intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancer in adults. This involves using microwaves to improve the effect of the chemotherapy given directly into the bladder. This guidance replaces NICE interventional procedures guidance on intravesical microwave